Zobrazeno 1 - 10
of 26
pro vyhledávání: '"D. A. Misurski"'
Publikováno v:
Applied Health Economics and Health Policy. 7:245-254
Background: Exenatide (Byetta) and insulin glargine (Lantus) are antidiabetic agents that are typically used after lack of response to an oral antidiabetic agent(s). Although previous research has examined the impact of these medications on glycaemic
Publikováno v:
Advances in Therapy. 26:217-229
Exenatide (Byetta, Amylin Pharmaceuticals Inc., CA, USA) and sitagliptin (Januvia, MerckCo, NJ, USA) are two antidiabetic agents recently approved by the US Food and Drug Administration. The purpose of this analysis was to compare costs among patient
Publikováno v:
The American Journal of Medicine. 120:381-387
It is widely accepted that hip and spine fractures are associated with substantial morbidity, but there is growing awareness that other fractures are under-recognized. The incidence of nonspinal, nonhip fractures is higher than for hip fractures beca
Publikováno v:
Osteoporosis International. 18:761-770
Prevalent vertebral fractures are associated with increased fracture risk, but the magnitude of this effect across a range of BMD T-scores has not been quantified. In this analysis, for any given BMD T-score, incident fracture risk varied up to twelv
Autor:
D. Goltzman, T. Dixon, P. M. Jakeman, S. J. Gallacher, T. V. Nguyen, Suzanne Satterfield, E. Barrett-Connor, Eric S. Orwoll, S. Boutroy, P. D. Miller, Brent C Taylor, E. Sornay-Rendu, J. Saunders, Howard A Fink, Lisa Palermo, F. Munoz, Silvina Levis, N. Rushe, Antonio Lombardi, William D. Leslie, N. M. Cummins, J. A. Cauley, J. A. Eisman, A. Tenenhouse, K. Siminoski, J. H. Krege, Dennis M. Black, G. Glaeske, A. Papaioannou, Lois E. Wehren, Sara A. Quandt, J. Prior, P. B. Rapuri, Johannes Pfeilschifter, Loren Joseph, J. C. Gallagher, J. Richards, K. Davison, P. J. Mitchell, R. Josse, L. Pientka, Doug C. Bauer, B. Häussler, Pierre D. Delmas, Kristine E. Ensrud, J. Adachi, D. Felsenberg, Cora E. Lewis, A. P. Gallagher, Susan K. Ewing, H. Gothe, D. Hanley, Steve Cummings, Robert B. Wallace, N. D. Nguyen, P. Chen, M. R. Towler, A. Wren, Arthur C. Santora, L. M. Smith, C. McQuillian, J S. Brown, D. A. Misurski, S. Morin, S. Mangiapane, Ann V. Schwartz, James M. Shikany
Publikováno v:
Osteologie/Osteology. 16:53-59
Publikováno v:
Bone. 39:1268-1275
Purpose: It is desirable for clinicians to know what bone mineral density (BMD) response they can expect in women treated with osteoporosis therapies. The focus of this analysis was to determine what percentage of women attained a lumbar spine BMD re
Publikováno v:
Osteoporosis International. 18:59-68
The prevalence of both osteoporosis and renal impairment increases with age.Using data from the Fracture Prevention Trial, the safety and efficacy of teriparatide [rhPTH(1-34)] in postmenopausal women with osteoporosis and renal impairment were explo
Publikováno v:
Journal of Clinical Densitometry. 9:144-149
Changes in lumbar spine bone mineral density (BMD) are determined by follow-up dual-energy x-ray absorptiometry (DXA) assessments. Inclusion of new or worsening vertebral fractures in follow-up measurements may increase BMD. To test this hypothesis,
Autor:
Richard M. Bergenstal, Lesley Ann Miller, Likun Hou, Amy Blickensderfer, Rolin L Wade, Anthony Zagar, Louis P. Garrison, Jamie Scism-Bacon, Matthew Wintle, William H. Herman, D. A. Misurski
Publikováno v:
Current medical research and opinion. 27(3)
To describe the Exenatide Observational Study (ExOS) and patients initiating exenatide therapy in a real-world clinical practice setting.ExOS is a prospective, single-arm, multicenter, observational study to assess the effectiveness of up to 24 month
Autor:
Paula J. Smith, Elise M Pelletier, Kristina S. Boye, Michael E. Minshall, Sandra L. Tunis, D. A. Misurski
Publikováno v:
Applied health economics and health policy. 6(2-3)
Medical complications are the key drivers of the direct medical costs of treating patients with type 2 diabetes mellitus. However, the published literature shows great variability across studies in the number and type of sources from which these cost